首頁 > 市場調查報告書 > 工業機械

自動化

市場調查報告書

商品編碼

1527226

自動化分析儀市場 - 全球產業規模、佔有率、趨勢、機會和預測，按分析儀、應用、地區和競爭細分，2019-2029F

Automated Analyzers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Analyzer, By Application, By Region and Competition, 2019-2029F

出版日期: 2024年08月02日 | 出版商:

TechSci Research | 英文 187 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年全球自動化分析儀市場估值為75.2 億美元，預計在預測期內將穩定成長，到2029 年複合年成長率為5.25%。分析儀等創新。這些先進設備從根本上改變了全世界的臨床實驗室實踐，最佳化了流程，提高了精確度，並最終提升了病患照護水準。

市場概況
預測期	2025-2029
2023 年市場規模	75.2億美元
2029 年市場規模	102.5億美元
2024-2029 年複合年成長率	5.25%
成長最快的細分市場	基於免疫的分析儀
最大的市場	北美洲

自動化分析儀是尖端儀器，旨在自動化各種實驗室功能，涵蓋樣品製備、分析和結果解釋。它們滿足從臨床化學和血液學到免疫測定和分子診斷的廣泛應用。透過自動化重複任務並最大限度地減少人為錯誤，這些分析儀顯著提高了實驗室效率和產量。

近年來，在多種因素的推動下，全球自動化分析儀市場經歷了顯著擴張。首先，慢性病和傳染病的盛行率不斷上升，需要快速、準確的診斷解決方案，從而推動了自動化分析儀的普及。此外，人工智慧和機器人技術的結合等技術進步透過增強儀器性能和功能推動了市場成長。此外，對預防性醫療保健和個人化醫療的日益關注刺激了對先進診斷工具（包括自動分析儀）的需求。此外，醫療保健支出的增加，特別是在新興市場，以及醫療保健基礎設施的擴張，為市場參與者開拓新市場和擴大客戶群創造了有利可圖的機會。

主要市場促進因素

實驗室自動化需求不斷成長

慢性病和傳染病的發生率上升

主要市場挑戰

成本壓力

互通性和整合

主要市場趨勢

技術進步

細分市場洞察

分析儀見解

區域洞察

Global Automated Analyzers Market was valued at USD 7.52 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In the contemporary healthcare sector, technological progress continually reshapes operations, particularly with innovations like automated analyzers. These advanced devices have fundamentally altered clinical laboratory practices worldwide, optimizing processes, boosting precision, and ultimately elevating patient care.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 7.52 Billion
Market Size 2029	USD 10.25 Billion
CAGR 2024-2029	5.25%
Fastest Growing Segment	Immuno-based Analyzers
Largest Market	North America

Automated analyzers are cutting-edge instruments engineered to automate diverse laboratory functions, spanning sample preparation, analysis, and result interpretation. They cater to a broad spectrum of applications, from clinical chemistry and hematology to immunoassay and molecular diagnostics. By automating repetitive tasks and minimizing human error, these analyzers significantly bolster laboratory efficiency and output.

The global market for automated analyzers has experienced significant expansion in recent years, fueled by various factors. Firstly, the escalating prevalence of chronic and infectious diseases demands swift and accurate diagnostic solutions, driving the uptake of automated analyzers. Additionally, technological advancements, such as the incorporation of artificial intelligence and robotics, have propelled market growth by enhancing instrument performance and capabilities. Furthermore, the increasing focus on preventive healthcare and personalized medicine has spurred demand for advanced diagnostic tools, including automated analyzers. Moreover, the uptick in healthcare spending, particularly in emerging markets, alongside the expansion of healthcare infrastructure, has created lucrative opportunities for market players to tap into new markets and broaden their customer base.

Key Market Drivers

Growing Demand for Laboratory Automation

In the realm of scientific research and diagnostics, precision and efficiency are paramount. Laboratories worldwide are increasingly turning to automation to streamline processes and enhance accuracy. The global market for automated analyzers, fueled by this growing demand for laboratory automation, is witnessing significant expansion. This surge is reshaping the landscape of scientific analysis, offering unprecedented opportunities for innovation and efficiency. Laboratory automation involves the integration of advanced technologies to perform tasks traditionally carried out by humans. From sample preparation to data analysis, automation minimizes human error, reduces turnaround times, and increases throughput. This transformative shift in laboratory workflows has been catalyzed by several factors. Firstly, the escalating complexity of scientific research and diagnostic testing necessitates higher throughput and accuracy. Manual processes are not only time-consuming but also prone to errors, potentially compromising results. Automated analyzers offer precise, reproducible results even in high-volume testing environments, meeting the demands of modern laboratories. Secondly, the advent of high-throughput screening techniques and advancements in robotics and artificial intelligence have made automation increasingly accessible and cost-effective. Laboratories can now automate a wide array of tasks, including sample handling, liquid handling, and data analysis, with greater ease and efficiency. Furthermore, the ongoing digitization of healthcare and laboratory information systems has facilitated seamless integration between automated analyzers and laboratory management software. This interconnectedness enables real-time monitoring, data management, and remote access, empowering laboratories to operate more efficiently and adapt to evolving research and diagnostic needs.

Rising Incidence of Chronic and Infectious Diseases

In recent years, the world has witnessed a significant rise in the prevalence of chronic and infectious diseases, leading to a growing demand for efficient diagnostic solutions. Automated analyzers have emerged as indispensable tools in healthcare facilities worldwide, offering accuracy, speed, and efficiency in diagnosing a wide range of diseases. As the burden of diseases continues to escalate, the global automated analyzers market is experiencing robust growth, driven by the urgent need for advanced diagnostic capabilities.

The increasing incidence of chronic diseases such as diabetes, cardiovascular disorders, cancer, and respiratory ailments has become a pressing global health concern. According to the World Health Organization (WHO), non-communicable diseases account for approximately 71% of all deaths worldwide, with cardiovascular diseases alone responsible for nearly 17.9 million deaths annually. Moreover, infectious diseases, including influenza, HIV/AIDS, tuberculosis, and emerging threats like COVID-19, continue to pose significant challenges to public health systems worldwide. Automated analyzers play a pivotal role in the timely and accurate diagnosis of various diseases. These sophisticated instruments utilize advanced technologies such as immunoassay, clinical chemistry, hematology, molecular diagnostics, and microbiology to analyze biological samples such as blood, urine, and tissue. By automating complex laboratory processes, these analyzers not only enhance diagnostic accuracy but also streamline workflow, reduce human error, and improve turnaround times, ultimately leading to better patient outcomes.

Key Market Challenges

Cost Pressures

Cost considerations pose a significant challenge for both manufacturers and end-users in the automated analyzers market. While advancements in technology have led to improved efficiency and cost-effectiveness, the initial investment required for acquiring automated analyzers can be substantial. Additionally, ongoing maintenance, calibration, and software updates incur additional expenses over the product's lifecycle. Moreover, fierce competition in the market exerts downward pressure on prices, squeezing profit margins and challenging manufacturers to balance affordability with quality and performance.

Interoperability and Integration

In today's interconnected world, interoperability and seamless integration have become essential requirements for automated analyzers to effectively communicate and exchange data with other systems and devices. However, achieving interoperability can be challenging due to the lack of standardized protocols, proprietary technologies, and compatibility issues between different manufacturers' products. Integration with existing infrastructure and laboratory information management systems (LIMS) also presents hurdles, requiring customized solutions and extensive testing to ensure compatibility and data integrity.

Key Market Trends

Technological Advancements

In recent years, the healthcare industry has witnessed a remarkable transformation propelled by technological advancements. Among these advancements, automated analyzers have emerged as a pivotal tool, revolutionizing diagnostic processes and laboratory workflows. The global automated analyzers market is experiencing significant growth, fueled by the relentless pursuit of efficiency, accuracy, and reliability in diagnostic testing across various sectors including healthcare, pharmaceuticals, and research institutions. Automated analyzers encompass a diverse range of instruments designed to automate the analysis of samples such as blood, urine, and tissues. These systems integrate sophisticated technologies such as robotics, artificial intelligence (AI), and advanced sensors to perform a wide array of tests rapidly and with minimal human intervention.

Automation streamlines laboratory workflows by eliminating manual processes, reducing human error, and significantly increasing the throughput of diagnostic tests. Automated analyzers can handle large volumes of samples efficiently, enabling laboratories to process more tests in a shorter time frame without compromising accuracy. Advanced algorithms and high-performance sensors incorporated into automated analyzers ensure precise and consistent results, enhancing the reliability of diagnostic testing. By minimizing variability and standardizing testing procedures, these systems contribute to better clinical outcomes and informed decision-making by healthcare professionals. While the initial investment in automated analyzers may be substantial, the long-term benefits in terms of operational efficiency and resource utilization are significant. Automated systems reduce the need for manual labor, minimize sample wastage, and optimize reagent usage, ultimately leading to cost savings for laboratories and healthcare facilities. The versatility of automated analyzers enables their application across diverse fields such as clinical diagnostics, drug discovery, forensic analysis, and environmental monitoring. As technological advancements continue to broaden the capabilities of these systems, new opportunities for their utilization in emerging areas of healthcare and research are constantly emerging, further driving market growth. The integration of AI, machine learning, and big data analytics into automated analyzers is revolutionizing diagnostic testing by enabling predictive analytics, personalized medicine, and real-time data insights. These technologies empower automated analyzers to adapt to evolving healthcare needs, optimize testing protocols, and facilitate early disease detection and intervention.

Segmental Insights

Analyzer Insights

Based on analyzer, Immuno-based Analyzers emerged as the dominant player in the global market for Automated Analyzers in 2023. Immuno-based analyzers have emerged as the preferred choice for a wide range of diagnostic applications. Immunoassays are analytical techniques that utilize the specific binding of antibodies to antigens for the detection and quantification of analytes in biological samples. This technology offers unparalleled sensitivity, specificity, and versatility, making it indispensable in clinical diagnostics. Immunoassays are renowned for their exceptional accuracy and sensitivity, allowing for the detection of analytes at very low concentrations. This capability is particularly crucial for diagnosing diseases in their early stages when biomarker levels may be extremely low.

Regional Insights

North America emerged as the dominant region in the global Automated Analyzers market in 2023, holding the largest market share in terms of value. North America boasts a robust ecosystem of research and development, with leading companies continuously investing in cutting-edge technologies to enhance automated analyzer capabilities. From advanced algorithms to integrated systems, these innovations drive market growth and maintain North America's competitive edge. The region is home to world-class healthcare infrastructure, characterized by state-of-the-art laboratories, well-equipped hospitals, and a strong regulatory framework. The presence of renowned healthcare institutions fosters the adoption of automated analyzers, driving market expansion and facilitating widespread access to diagnostic services.

Key Market Players

Thermo Fisher Scientific Inc.

Danaher Corporation

Hudson Robotics Inc.

Becton Dickinson and Company

Synchron

Agilent Technologies Inc.

Siemens Healthineers AG

Tecan Trading AG

PerkinElmer Inc.

Honeywell International Inc.

Report Scope:

In this report, the Global Automated Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated Analyzers Market, By Analyzer:

Biochemistry Analyzers Immuno-based Analyzers Hematology Analyzers

Automated Analyzers Market, By Application:

Drug Discovery Genomics Proteomics Bioanalysis Analytical Chemistry Clinical Diagnostics

Automated Analyzers Market, By Region:

United States
Canada
Mexico

France
United Kingdom
Italy
Germany
Spain

China
India
Japan
Australia
South Korea

Brazil
Argentina
Colombia

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Automated Analyzers Market.

Available Customizations:

Global Automated Analyzers market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Automated Analyzers Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Analyzer (Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers)
- 5.2.2. By Application (Drug Discovery, Genomics, Proteomics, Bioanalysis, Analytical Chemistry, Clinical Diagnostics)
- 5.2.3. By Company (2023)
- 5.2.4. By Region
5.3. Market Map

6. North America Automated Analyzers Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Analyzer
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Automated Analyzers Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Analyzer
    - 6.3.1.2.2. By Application
- 6.3.2. Mexico Automated Analyzers Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Analyzer
    - 6.3.2.2.2. By Application
- 6.3.3. Canada Automated Analyzers Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Analyzer
    - 6.3.3.2.2. By Application

7. Europe Automated Analyzers Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Analyzer
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Automated Analyzers Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Analyzer
    - 7.3.1.2.2. By Application
- 7.3.2. Germany Automated Analyzers Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Analyzer
    - 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Automated Analyzers Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Analyzer
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Automated Analyzers Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Analyzer
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Automated Analyzers Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Analyzer
    - 7.3.5.2.2. By Application

8. Asia-Pacific Automated Analyzers Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Analyzer
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Automated Analyzers Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Analyzer
    - 8.3.1.2.2. By Application
- 8.3.2. India Automated Analyzers Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Analyzer
    - 8.3.2.2.2. By Application
- 8.3.3. South Korea Automated Analyzers Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Analyzer
    - 8.3.3.2.2. By Application
- 8.3.4. Japan Automated Analyzers Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Analyzer
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Automated Analyzers Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Analyzer
    - 8.3.5.2.2. By Application

9. South America Automated Analyzers Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Analyzer
- 9.2.2. By Application
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Automated Analyzers Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Analyzer
    - 9.3.1.2.2. By Application
- 9.3.2. Argentina Automated Analyzers Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Analyzer
    - 9.3.2.2.2. By Application
- 9.3.3. Colombia Automated Analyzers Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Analyzer
    - 9.3.3.2.2. By Application

10. Middle East and Africa Automated Analyzers Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Analyzer
- 10.2.2. By Application
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Automated Analyzers Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Analyzer
    - 10.3.1.2.2. By Application
- 10.3.2. Saudi Arabia Automated Analyzers Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Analyzer
    - 10.3.2.2.2. By Application
- 10.3.3. UAE Automated Analyzers Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Analyzer
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Porters Five Forces Analysis

13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Thermo Fisher Scientific Inc.
- 14.1.1. Business Overview
- 14.1.2. Company Snapshot
- 14.1.3. Products & Services
- 14.1.4. Financials (As Reported)
- 14.1.5. Recent Developments
- 14.1.6. Key Personnel Details
- 14.1.7. SWOT Analysis
14.2. Danaher Corporation
14.3. Hudson Robotics Inc.
14.4. Becton Dickinson and Company
14.5. Synchron
14.6. Agilent Technologies Inc.
14.7. Siemens Healthineers AG
14.8. Tecan Trading AG
14.9. PerkinElmer Inc.
14.10. Honeywell International Inc.